Abstract
Chronic lymphocytic leukemia (CLL) is a common hematological malignancy. This study is aimed to investigate the prognostic effect of clinic, laboratory and flow cytometric analysis in CLL patients. Newly diagnosed 55 CLL cases were divided into two groups, as stable disease (Group 1) and progressive disease (Group 2). Group 1 included those who did not require any treatment since diagnosis and those who did not progress after receiving the first step anti CLL treatment. Group 2 included the patients who received ≥ 2 steps treatment. The relation between the two groups was analyzed statistically in terms of clinical, laboratory and flow cytometric findings. Twenty patients (36.3%) required treatment at the time of diagnosis, four patients (3.8%) received first-line treatment during follow-up and 31 (56.3%) patients were followed without any treatment. Thirteen patients required second step treatment after a median of 26.3 months. The risk of progression was found to be increased 5-fold (p = 0.015) in the CD38 positive patient group, 4.2-fold (p = 0.0147) in the FMC7 negative patient group and 2.8-fold in the CD11c negative patient group. FMC 7 negativity decreased total survival 5.9-fold (p = 0.051). Unlike similar publications,...Continue Reading
References
Dec 1, 1991·The Journal of Experimental Medicine·A A PostigoM O de Landázuri
Nov 1, 1990·British Journal of Haematology·D G OscierM Fitchett
Dec 1, 1987·Cancer·S Molica, A Alberti
Mar 1, 1986·British Journal of Haematology·E MontserratC Rozman
Jul 1, 1981·Cancer·J L BinetF Gremy
Nov 9, 2001·Leukemia & Lymphoma·G D'ArenaM Carotenuto
Feb 13, 2002·Leukemia·J DürigU Dührsen
Aug 16, 2002·British Journal of Haematology·Tryfonia Mainou-FowlerGeoffrey P Summerfield
Oct 3, 2003·Leukemia·J DürigU Dührsen
Feb 15, 2007·Blood·William G WierdaMichael Keating
Mar 16, 2007·Leukemia·A C RawstronP Hillmen
Sep 19, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Avadhut D JoshiShantaram S Joshi
Jan 25, 2008·Blood·Michael HallekUNKNOWN International Workshop on Chronic Lymphocytic Leukemia
May 2, 2008·Blood Reviews·Carol Moreno, Emili Montserrat
Nov 3, 2011·British Journal of Cancer·A SmithE Roman
Jul 22, 2014·British Journal of Haematology·Massimo GentileFortunato Morabito
Sep 1, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B EichhorstUNKNOWN ESMO Guidelines Committee
Oct 16, 2015·European Journal of Immunology·Shivajanani SivakumaranClare L Bennett
Oct 16, 2015·Nature·Dan A LandauCatherine J Wu
Dec 1, 2015·Cancer Control : Journal of the Moffitt Cancer Center·Lodovico Balducci, Dawn Dolan
Dec 1, 2015·Cancer Control : Journal of the Moffitt Cancer Center·Javier Pinilla-Ibarz, Josephine Emole
Jun 13, 2017·International Journal of Laboratory Hematology·E G UmitA M Demir
Nov 11, 2017·Blood Reviews·Alain MinaMohamed A Kharfan-Dabaja